These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29285810)

  • 41. From pressure overload to volume overload: aortic regurgitation after transcatheter aortic valve implantation.
    Gotzmann M; Lindstaedt M; Mügge A
    Am Heart J; 2012 Jun; 163(6):903-11. PubMed ID: 22709742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Post-Procedural Aortic Regurgitation After TAVR: An Intraprocedural TEE Study.
    Mihara H; Shibayama K; Jilaihawi H; Itabashi Y; Berdejo J; Utsunomiya H; Siegel RJ; Makkar RR; Shiota T
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):993-1003. PubMed ID: 26319501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Von Willebrand Factor--A Rapid Sensor of Paravalvular Regurgitation during TAVR?
    Zahr FE; Lentz SR
    N Engl J Med; 2016 Jul; 375(4):382-3. PubMed ID: 27464206
    [No Abstract]   [Full Text] [Related]  

  • 44. Three-dimensional multidetector computed tomography versus conventional 2-dimensional transesophageal echocardiography for annular sizing in transcatheter aortic valve replacement: Influence on postprocedural paravalvular aortic regurgitation.
    Hansson NC; Thuesen L; Hjortdal VE; Leipsic J; Andersen HR; Poulsen SH; Webb JG; Christiansen EH; Rasmussen LE; Krusell LR; Terp K; Klaaborg KE; Tang M; Lassen JF; Bøtker HE; Nørgaard BL
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):977-86. PubMed ID: 23703899
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation.
    Colli A; D'Amico R; Kempfert J; Borger MA; Mohr FW; Walther T
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1229-35. PubMed ID: 22014345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Balloon-expandable transcatheter aortic valve replacement in patients with extreme aortic valve calcification.
    Abramowitz Y; Jilaihawi H; Chakravarty T; Kashif M; Matar G; Hariri B; Patel J; Nakamura M; Cheng W; Makkar RR
    Catheter Cardiovasc Interv; 2016 May; 87(6):1173-9. PubMed ID: 26527374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of transcutaneous aortic valve implantation on the Heyde's syndrome.
    Benton SM; Kumar A; Crenshaw M; Fredi JL
    Am J Cardiol; 2014 Sep; 114(6):953-4. PubMed ID: 25208564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve).
    Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB
    J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of transcatheter aortic valve implantation in high surgical risk and inoperable patients with aortic stenosis: a single Australian Centre experience.
    Subban V; Murdoch D; Savage ML; Crowhurst J; Saireddy R; Poon KK; Incani A; Bett N; Burstow DJ; Scalia GM; Clarke A; Raffel OC; Aroney CN; Walters DL
    Intern Med J; 2016 Jan; 46(1):42-51. PubMed ID: 26482426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation.
    Gripari P; Ewe SH; Fusini L; Muratori M; Ng AC; Cefalù C; Delgado V; Schalij MJ; Bax JJ; Marsan NA; Tamborini G; Pepi M
    Heart; 2012 Aug; 98(16):1229-36. PubMed ID: 22826560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resolution of acquired von Willebrand syndrome after transcatheter aortic valve implantation through a left transcarotid approach.
    Pozzi M; Hanss M; Petrosyan A; Vedrinne C; Green L; Dementhon J; Pizzighini S; Rioufol G; Finet G; Obadia JF
    Int J Cardiol; 2014 Oct; 176(3):1350-1. PubMed ID: 25129274
    [No Abstract]   [Full Text] [Related]  

  • 54. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
    Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
    Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcatheter aortic valve implantation: Anesthetic experience of retrograde transfemoral approach with CoreValve ReValving System.
    Chou WH; Wang YC; Huang HH; Cheng HL; Lin YS; Wang MJ; Huang CH
    Acta Anaesthesiol Taiwan; 2014 Mar; 52(1):2-5. PubMed ID: 24999211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcatheter Aortic and Mitral Valve Implantation (TAMVI) in Native Rheumatic Valves.
    Akujuo AC; Dellis SL; Britton LW; Bennett EV
    J Card Surg; 2015 Nov; 30(11):813-6. PubMed ID: 26347492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
    Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
    Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis.
    Sherif MA; Abdel-Wahab M; Stöcker B; Geist V; Richardt D; Tölg R; Richardt G
    J Am Coll Cardiol; 2010 Nov; 56(20):1623-9. PubMed ID: 21050971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis.
    Babaliaros V; Devireddy C; Lerakis S; Leonardi R; Iturra SA; Mavromatis K; Leshnower BG; Guyton RA; Kanitkar M; Keegan P; Simone A; Stewart JP; Ghasemzadeh N; Block P; Thourani VH
    JACC Cardiovasc Interv; 2014 Aug; 7(8):898-904. PubMed ID: 25086843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
    Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
    Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.